open access

Vol 6, Supp. A (2010)
suplement
Published online: 2010-11-22
Get Citation

Treatment for advanced metastatic breast cancer, after use the total recommended cumulated dose of doxorubicin

Anna Majstrak, Iwona Głogowska, Izabela Lemańska, Tadeusz Pieńkowski

open access

Vol 6, Supp. A (2010)
suplement
Published online: 2010-11-22

Abstract

Anthracyclines are one of the most effective treatments for breast cancer, but their use is limited by dose- -related cardiotoxicity. Treatment with liposomal doxorubicine is a feasible alternative. We present a case of a patient with bilateral metastatic breast cancer affecting the liver who had already received the total recommended cumulated dose of doxorubicin for the treatment of cancer in the first affected breast. The patient was subsequently treated with non-pegylated liposomal doxorubicin for progression of the disease to the liver and dramatic remission of the liver metastatic sites was achieved.
Onkol. Prak. Klin. 2010; supl. A: A47–A50

Abstract

Anthracyclines are one of the most effective treatments for breast cancer, but their use is limited by dose- -related cardiotoxicity. Treatment with liposomal doxorubicine is a feasible alternative. We present a case of a patient with bilateral metastatic breast cancer affecting the liver who had already received the total recommended cumulated dose of doxorubicin for the treatment of cancer in the first affected breast. The patient was subsequently treated with non-pegylated liposomal doxorubicin for progression of the disease to the liver and dramatic remission of the liver metastatic sites was achieved.
Onkol. Prak. Klin. 2010; supl. A: A47–A50
Get Citation

Keywords

breast cancer; anthracyclines; cardiotoxicity; non-pegylated liposomal doxorubicin

About this article
Title

Treatment for advanced metastatic breast cancer, after use the total recommended cumulated dose of doxorubicin

Journal

Oncology in Clinical Practice

Issue

Vol 6, Supp. A (2010)

Pages

47-50

Published online

2010-11-22

Keywords

breast cancer
anthracyclines
cardiotoxicity
non-pegylated liposomal doxorubicin

Authors

Anna Majstrak
Iwona Głogowska
Izabela Lemańska
Tadeusz Pieńkowski

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl